Facebook Twitter Instagram
    • Home
    • About Journal
      • Aim and Scope
      • Editorial Board
      • Indexing Info
      • Contact Us
    • Browse Issues
      • Articles in Press
      • Current Issue
      • Past Issues
    • For Authors
      • Instructions to Authors
      • Article Processing Charges
      • Submit your article
      • Downloads
    Facebook Twitter Instagram
    Pharmacognosy Communications
    • Home
    • About Journal
      • Aim and Scope
      • Editorial Board
      • Indexing Info
      • Contact Us
    • Browse Issues
      • Articles in Press
      • Current Issue
      • Past Issues
    • For Authors
      • Instructions to Authors
      • Article Processing Charges
      • Submit your article
      • Downloads
    Pharmacognosy Communications
    retyeyutreu
    Research Article

    Anticancer effect of lemongrass oil and citral on cervical cancer cell lines

    wadmin2By wadmin2December 2, 2013Updated:August 10, 2021No Comments2 Mins Read
    Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp Email
    Share
    Facebook Twitter LinkedIn WhatsApp Pinterest Email

    Kavisa Ghosh*
    Department of Zoology, Annamalai University, Annamalainagar, Chidambaram 608002

    Pharmacognosy Communications,2013,3,4,41-48.
    DOI:10.5530/pc.2013.4.6
    Published:December 2013
    Type:Research Article

    ABSTRACT

    Aims: The aim of the present study was to evaluate the anticancer effect of lemongrass oil and citral emulsion on cervical cancer cell lines (HeLa and ME-180) in vitro. Settings and Design: Citral is a very important component in lemongrass oil. It is proved to have anticancer properties in various human cancer cell lines. Methods and Material: DLS analysis revealed the average size of the lemongrass oil emulsion to be 267 nm and the average size of the citral emulsion to be 270 nm. The anticancer effect of both the emulsions was determined by MTT assay, DCFH-DA method, Rh-123 and AO/EtBr-staining. Statistical analysis used: One-way ANOVA followed by DMRT taking p<0.05 to test the significant difference between groups. Results: The results summarize that lemongrass oil and citral emulsions initiate the cancer cell death by decreasing cell proliferation, increasing intracellular ROS, altering mitochondrial membrane potential, and initiating apoptosis in HeLa and ME-180 cell lines. The present findings of this study clearly demonstrate the involvement of oxidative mechanism for the anti-proliferative effect in HeLa and ME-180 cell lines. ME-180 being chemosensitive showed good results at lower concentrations of citral (IC50 24 h 300 μg/ml), as compared to chemoresistant HeLa cells (citral IC50 24 h 500 μg/ml). Whereas lemongrass oil exhibited better activity in both the cell lines (IC50 24 h 200 μg/ml). Conclusions: All the results suggest lemongrass oil and citral emulsion could be considered as potent candidates for anticancer agents.

    Keywords: Lemongrass oil, Citral, Emulsion, Anticancer, HeLa, ME-180

    Key message: Lemongrass oil and citral emulsion are potent candidates for anticancer ointment based drugs.

    Download PDF
    Share. Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp Email
    About Journal
    About Journal

    Pharmacognosy Communications [Phcog Commn.] is a quarterly journal published by Phcog.Net. It is a peer reviewed journal aiming to publish high quality original research articles, methods, techniques and evaluation reports, critical reviews, short communications, commentaries and editorials of all aspects of medicinal plant research. The journal is aimed at a broad readership, publishing articles on all aspects of pharmacognosy, and related fields. The journal aims to increase understanding of pharmacognosy as well as to direct and foster further research through the dissemination of scientific information by the publication of manuscripts. The submission of original contributions in all areas of pharmacognosy are welcome.
    Indexed and Abstracted in : Chemical Abstracts, Excerpta Medica / EMBASE, Google Scholar, CABI Full Text, Ulrich’s International Periodical Directory, ProQuest, Journalseek & Genamics, PhcogBase, EBSCOHost, Academic Search Complete, Open J-Gate, SciACCESS.
    Rapid publication: Average time from submission to first decision is 30 days and from acceptance to In Press online publication is 45 days.
    Open Access Journal: Phcog Commn. is an open access journal, which allows authors to fund their article to be open access from publication.

    © 2025 Pharmacognosy Communications. Maintained by Manuscript TechnoMedia LLP.

    Type above and press Enter to search. Press Esc to cancel.

    Scroll Up